MDC 0.00% $6.60 medlab clinical limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-28

  1. 161 Posts.
    lightbulb Created with Sketch. 27
    thanks Apse. you seemed to be quite knowledgeable with company information .
    you have answered the question in 2nd point- "lock down big pharma partnerships on nanocelle". This is core business model of all DRUG DELIVERY PLATFORM companies - the ultimate dream.
    offcourse MDC can pursue other interests but validate that nanocelle can stand within mass market first and secure some solid revenue stream.
 
watchlist Created with Sketch. Add MDC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.